Status:
COMPLETED
Evaluation of Eye Health Benefits of Blueberry Chewable Tablets
Lead Sponsor:
TCI Co., Ltd.
Conditions:
Eye
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
To assess the efficacy of blueberry chewable tablets on Eye Health
Eligibility Criteria
Inclusion
- Adult men and women over 20 years old
- Use 3C products over 6 hours per day
- Symptoms of dry eyes or tired eyes
- Tear Break-Up Time is 10 seconds less
- No history of ocular surgery (strabismus surgery, refractive surgery etc.)
Exclusion
- Have systemic diseases affecting the front surface of the eyes.
- Long-term use of drugs or eye drops that affect the condition of the front surface of the eyes
- Long-term contact lens wear
Key Trial Info
Start Date :
April 17 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04348110
Start Date
April 17 2020
End Date
December 31 2020
Last Update
January 15 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chung Shan Medical University
Taichung, Taiwan, 402